Reuters.Meanwhile, nations across the world are racing to develop Covid-19 vaccines and treatments, and the rapid pace of development has had doctors and experts concerned about transparency and regulatory reviews.The FDA said it recognises disclosing such information would also contribute to the public's confidence in the agency's rigorous review of scientific data."We will also continue to follow the science and ensure that science remains the driver of the agency's regulatory decision-making in our fight against COVID-19 and beyond on behalf of public health," Hahn added.The FDA, an agency within the US Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and.